Conversely, CRC cell viability, migration, invasion, EMT, and TGF-β/SMAD and JAK/STAT3 activation were inhibited by miR-128-3p interference and FOXO4 overexpression. The gene discussed is FOXO4; the disease is colorectal carcinoma.